GlassScriptEurofins Viracor, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$25Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
307clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| David Baran | Weston, FL | Advanced Heart Failure and Transplant Cardiology | $518.16 |
| Oluwafisayo Adebiyi | Indianapolis, IN | Nephrology (Internal Medicine) | $518.16 |
| Joanna Schaenman | Santa Monica, CA | Infectious Disease | $518.16 |
| Layla Kamal | Richmond, VA | Nephrology (Internal Medicine) | $518.16 |
| Joseph Kremer | Cincinnati, OH | Nephrology (Internal Medicine) | $422.75 |
| Chonyang Albert | Cleveland, OH | Advanced Heart Failure and Transplant Cardiology | $416.72 |
| Clifford Miles | Omaha, NE | Nephrology (Internal Medicine) | $405.62 |
| Jagpreet Grewal | New Brunswick, NJ | Cardiovascular Disease | $285.65 |
| Laurie Davis | San Antonio, TX | Pediatric Hematology-Oncology | $283.14 |
| Damiano Rondelli | Chicago, IL | Hematology & Oncology | $283.14 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.